Shimono et al. showed a decrease in the expression of the miR-200 family (miR-200a/-200b/-200c, miR-101, miR-182miR-183, and miR-96) in CD44+CD24-/low lineage-primary breast cancer stem cells [36]. This evidence concerns the gene CD44 and breast carcinoma.